Galectin Therapeutics (GALT) Assets (2010 - 2026)
Galectin Therapeutics' Assets was $14.83 million in Q2 2026, down 5.0% from $15.6 million a year earlier and down 5.9% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assets at Galectin Therapeutics came in at $19.53 million, up 11.6% from FY2024.
- Assets shows a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- In earlier years, Assets was $17.5 million in FY2024 (-38.0%), $28.2 million in FY2023 (+32.5%), $21.29 million in FY2022 (-49.1%) and $41.83 million in FY2021 (+41.3%).
- Quarterly Assets has moved between $9.53 million (Q1 2025) and $41.83 million (Q4 2021) over five years.
- Compared with a year earlier, Assets was higher in three of the last eight quarters, with an average decline of 12.2%.
- The best year-over-year quarter for Assets over five years was Q1 2026 (growth of 65.4%); the worst was Q1 2025 (a decline of 63.2%).
- Per Business Quant data, GALT's Assets in the three quarters before Q2 2026 was $15.76 million (Q1 2026), $19.53 million (Q4 2025) and $12.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Galectin Therapeutics | 260.61 Mn | 260.61 Mn | - | 14.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.83 Mn |
| Mar 31, 2026 | 15.76 Mn |
| Dec 31, 2025 | 19.53 Mn |
| Sep 30, 2025 | 12.87 Mn |
| Jun 30, 2025 | 15.60 Mn |
| Mar 31, 2025 | 9.53 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 28.97 Mn |
| Jun 30, 2024 | 27.66 Mn |
| Mar 31, 2024 | 25.89 Mn |
| Dec 31, 2023 | 28.20 Mn |
| Sep 30, 2023 | 22.16 Mn |
| Jun 30, 2023 | 20.08 Mn |
| Mar 31, 2023 | 20.23 Mn |
| Dec 31, 2022 | 21.29 Mn |
| Sep 30, 2022 | 17.91 Mn |
| Jun 30, 2022 | 25.89 Mn |
| Mar 31, 2022 | 33.62 Mn |
| Dec 31, 2021 | 41.83 Mn |
| Sep 30, 2021 | 38.04 Mn |
API Access
Galectin Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();